Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia-Reference-Cited by-同舟云学术

Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia

Published:2021-08-18 Issue:9 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Khan Ayesha¹²^ORCID,Arias Cesar A.¹²³⁴,Abbott April⁵,Dien Bard Jennifer⁶^ORCID,Bhatti Micah M.⁷,Humphries Romney M.⁸^ORCID

Affiliation:

1. Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, Houston, Texas, USA

2. Division of Infectious Diseases, McGovern Medical School, UTHealth, Houston, Texas, USA

3. Center for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA

4. Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia

5. Deaconess Health System, Indiana University Medical School, Evansville, Indiana, USA

6. Department of Pathology and Laboratory Medicine, Children’s Hospital of Los Angeles, Keck school of Medicine, University of Southern California, Los Angeles, California, USA

7. Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, Texas, USA

8. Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Abstract

Stenotrophomonas maltophilia causes high-mortality infections in immunocompromised hosts with limited therapeutic options. Many U.S. laboratories rely on commercial automated antimicrobial susceptibility tests (cASTs) and use CLSI breakpoints (BPs) for S. maltophilia .

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00654-21

Reference18 articles.

1. Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

2. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review

3. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations

4. Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance

5. Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long Story Short: Establishing Breakpoints for Antimicrobials and 2023 Updates;Current Infectious Disease Reports;2024-01-18

2. Accessory genes define species-specific routes to antibiotic resistance;Life Science Alliance;2024-01-16

3. Treatment approaches for severe Stenotrophomonas maltophilia infections;Current Opinion in Infectious Diseases;2023-10-16

4. Evaluation of phenotypical and genotypical methods for the identification and typing of Stenotrophomonas maltophilia isolated from a pharmaceutical facility;Journal of Applied Microbiology;2023-10

5. Evaluation of VITEK® 2 AST cards (AST-N376 and AST-N397) for susceptibility testing of challenging Gram negatives;Diagnostic Microbiology and Infectious Disease;2023-10